Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

前立腺がんのスクリーニング

W J Catalona

    Lancet (London, England)
    |June 4, 1994
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Does prostate volume correlate with vitamin D deficiency among men undergoing prostate biopsy?

    Prostate cancer and prostatic diseases·2016
    Same author

    T rosette assay: in vitro correlate of cellular immunity.

    Urology·2011
    Same author

    Mutant L Homologue 1 (MLH1): a possible new immunohistochemical marker for prostatic cancer.

    Histopathology·2007
    Same author

    Characterization of a method for profiling gene expression in cells recovered from intact human prostate tissue using RNA linear amplification.

    Prostate cancer and prostatic diseases·2006
    Same author

    TGFBR1*6A is not associated with prostate cancer in men of European ancestry.

    Prostate cancer and prostatic diseases·2004
    Same author

    Expression and initial promoter characterization of PCAN1 in retinal tissue and prostate cell lines.

    Medical oncology (Northwood, London, England)·2004
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る